Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31,294,939
-
Number of holders
-
230
-
Total 13F shares, excl. options
-
28,969,343
-
Shares change
-
-274,809
-
Total reported value, excl. options
-
$2,785,452,635
-
Value change
-
-$21,520,391
-
Put/Call ratio
-
48.92%
-
Number of buys
-
116
-
Number of sells
-
-97
-
Price
-
$96.15
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q3 2019
266 filings reported holding CNMD - CONMED Corp - Common Stock as of Q3 2019.
CONMED Corp - Common Stock (CNMD) has 230 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28,969,343 shares
of 31,294,939 outstanding shares and own 92.57% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4,280,061 shares), VANGUARD GROUP INC (2,926,781 shares), Capital Research Global Investors (2,270,162 shares), DIMENSIONAL FUND ADVISORS LP (1,360,954 shares), Champlain Investment Partners, LLC (1,310,440 shares), STATE STREET CORP (912,766 shares), MACQUARIE GROUP LTD (720,059 shares), PRINCIPAL FINANCIAL GROUP INC (713,008 shares), NORTHERN TRUST CORP (648,558 shares), and Capital World Investors (600,000 shares).
This table shows the top 230 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.